Diabetes, Vol 49, Issue 2 202-208, Copyright © 2000 by American Diabetes Association

ARTICLES

Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes

E Bonifacio, V Lampasona, L Bernasconi and AG Ziegler
Istituto Scientifico San Raffaele, Milan, Italy. bonifacio.ezio@hsr.it

GAD is a major target of autoimmunity in preclinical type 1 diabetes. Here we examine the maturation of the humoral response to GAD epitopes sequentially from birth to diabetes onset or current follow-up in 29 GAD antibody (GADA)+ offspring of parents with diabetes from the BABYDIAB Study. Antibodies were measured against GAD65, GAD67, and GAD65/67 chimeras by radiobinding assay. In 28 of 29 offspring, the first GADAs contained reactivity against epitopes within GAD65 residues 96-444, suggesting that the middle GAD65 region is a primary target of GAD humoral autoimmunity. In 7 of these 28 offspring, initial antibody reactivity was against all epitope regions tested (middle GAD65, COOH-terminal GAD65 residues 445-585, NH2-terminal GAD65 residues 1-95, and GAD67); in 16 offspring, reactivity was to middle and COOH-terminal GAD65 epitopes, and in 5 offspring, reactivity was only to the middle GAD65 epitopes. The single offspring without middle GAD65 reactivity had antibodies to the NH2-terminal epitopes in the absence of all other islet autoimmunity. Subsequent GADA epitope spreading was frequent and seen in 10 of 15 offspring with informative follow-up samples. Spreading was mostly (eight cases) to NH2-terminal GAD65 epitopes. In two offspring, spreading to new epitopes was found when antibody titers to GAD65 and early epitopes were declining, suggesting determinant-specific regulation of the humoral response. None of the GADA reactivities nor any changes in reactivity over time were specifically associated with diabetes onset. The findings suggest that the humoral autoimmune response to GAD found in childhood is dynamic, is initially against epitopes within the middle portion of GAD65, and spreads to epitopes in other regions of GAD65 and GAD67.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Mayr, M. Schlosser, N. Grober, H. Kenk, A. G. Ziegler, E. Bonifacio, and P. Achenbach GAD Autoantibody Affinity and Epitope Specificity Identify Distinct Immunization Profiles in Children at Risk for Type 1 Diabetes Diabetes, June 1, 2007; 56(6): 1527 - 1533. [Abstract] [Full Text] [PDF]

				S.-H. Lee, H. Lee, J.-S. Park, H. Choi, K.-Y. Han, H.-S. Seo, K.-Y. Ahn, S.-S. Han, Y. Cho, K.-H. Lee, et al. A novel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles FASEB J, May 1, 2007; 21(7): 1324 - 1334. [Abstract] [Full Text] [PDF]

				R. Buzzetti, S. Di Pietro, A. Giaccari, A. Petrone, M. Locatelli, C. Suraci, M. Capizzi, M. L. Arpi, E. Bazzigaluppi, F. Dotta, et al. High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes Diabetes Care, April 1, 2007; 30(4): 932 - 938. [Abstract] [Full Text] [PDF]

				M. S Ronkainen, S. Hoppu, S. Korhonen, S. Simell, R. Veijola, J. Ilonen, O. Simell, and M. Knip Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes. Eur. J. Endocrinol., October 1, 2006; 155(4): 633 - 642. [Abstract] [Full Text] [PDF]

				M. S Ronkainen, T. Harkonen, J. Perheentupa, and M. Knip Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes Eur. J. Endocrinol., December 1, 2005; 153(6): 901 - 906. [Abstract] [Full Text] [PDF]

				P. Achenbach, E. Bonifacio, K. Koczwara, and A.-G. Ziegler Natural History of Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S25 - S31. [Abstract] [Full Text] [PDF]

				C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark Autoantibodies in Diabetes Diabetes, December 1, 2005; 54(suppl_2): S52 - S61. [Abstract] [Full Text] [PDF]

				M. Maioli, E. Alejandro, G. Tonolo, L. K. Gilliam, L. Bekris, C. S. Hampe, D. A. Obinu, A. Manconi, L. Puddu, K. Lynch, et al. Epitope-Restricted 65-Kilodalton Glutamic Acid Decarboxylase Autoantibodies among New-Onset Sardinian Type 2 Diabetes Patients Define Phenotypes of Autoimmune Diabetes J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5675 - 5682. [Abstract] [Full Text] [PDF]

				P. Achenbach, K. Warncke, J. Reiter, H. E. Naserke, A. J.K. Williams, P. J. Bingley, E. Bonifacio, and A.-G. Ziegler Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics Diabetes, February 1, 2004; 53(2): 384 - 392. [Abstract] [Full Text] [PDF]

				C. J. Padoa, J. P. Banga, A.-M. Madec, M. Ziegler, M. Schlosser, E. Ortqvist, I. Kockum, J. Palmer, O. Rolandsson, K. A. Binder, et al. Recombinant Fabs of Human Monoclonal Antibodies Specific to the Middle Epitope of GAD65 Inhibit Type 1 Diabetes-Specific GAD65Abs Diabetes, November 1, 2003; 52(11): 2689 - 2695. [Abstract] [Full Text] [PDF]

				N. Li, V. Aoki, G. Hans-Filho, E. A. Rivitti, and L. A. Diaz The Role of Intramolecular Epitope Spreading in the Pathogenesis of Endemic Pemphigus Foliaceus (Fogo Selvagem) J. Exp. Med., June 2, 2003; 197(11): 1501 - 1510. [Abstract] [Full Text] [PDF]

				M. Hummel, E. Bonifacio, H. E. Naserke, and A. G. Ziegler Elimination of Dietary Gluten Does Not Reduce Titers of Type 1 Diabetes-Associated Autoantibodies in High-Risk Subjects Diabetes Care, July 1, 2002; 25(7): 1111 - 1116. [Abstract] [Full Text] [PDF]

				R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood, February 1, 2002; 99(3): 768 - 784. [Abstract] [Full Text] [PDF]

				S. Winer, I. Astsaturov, R. Gaedigk, D. Hammond-McKibben, M. Pilon, A. Song, V. Kubiak, W. Karges, E. Arpaia, C. McKerlie, et al. ICA69null Nonobese Diabetic Mice Develop Diabetes, but Resist Disease Acceleration by Cyclophosphamide J. Immunol., January 1, 2002; 168(1): 475 - 482. [Abstract] [Full Text] [PDF]

				E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, G. Pozza, A. Secchi, and E. Bonifacio Autoantibody Response to Islet Transplantation in Type 1 Diabetes Diabetes, November 1, 2001; 50(11): 2464 - 2471. [Abstract] [Full Text] [PDF]

				H. E. Naserke, E. Bonifacio, and A.-G. Ziegler Prevalence, Characteristics and Diabetes Risk Associated with Transient Maternally Acquired Islet Antibodies and Persistent Islet Antibodies in Offspring of Parents with Type 1 Diabetes J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4826 - 4833. [Abstract] [Full Text] [PDF]

				C. S. Hampe, L. P. Hammerle, L. Bekris, E. Örtqvist, I. Kockum, O. Rolandsson, M. Landin-Olsson, C. Törn, B. Persson, and A. Lernmark Recognition of Glutamic Acid Decarboxylase (GAD) by Autoantibodies from Different GAD Antibody-Positive Phenotypes J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4671 - 4679. [Abstract] [Full Text]

				M. A. Myers, J. M. Davies, J. C. Tong, J. Whisstock, M. Scealy, I. R. Mackay, and M. J. Rowley Conformational Epitopes on the Diabetes Autoantigen GAD65 Identified by Peptide Phage Display and Molecular Modeling J. Immunol., October 1, 2000; 165(7): 3830 - 3838. [Abstract] [Full Text] [PDF]